Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

BROKER RATINGS: Bernstein Lifts Reckitt; Liberum Cuts Moneysupermarket

Mon, 15th Feb 2021 09:40

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

----------

FTSE 100

----------

BERNSTEIN RAISES RECKITT BENCKISER TO 'MARKET-PERFORM' ('UNDERPERFORM')

----------

LIBERUM CUTS ASTRAZENECA PRICE TARGET TO 9,060 (9,600) PENCE - 'BUY'

----------

GOLDMAN SACHS CUTS HIKMA PHARMACEUTICALS PRICE TARGET TO 2,850 (3,050) PENCE - 'BUY'

----------

UBS CUTS ROLLS-ROYCE PRICE TARGET TO 111 (157) PENCE - 'NEUTRAL'

----------

JPMORGAN RAISES COCA-COLA HBC PRICE TARGET TO 2,750 (2,700) PENCE - 'OVERWEIGHT'

----------

FTSE 250

----------

LIBERUM CUTS MONEYSUPERMARKET.COM TO 'HOLD' ('BUY') - TARGET 290 (335) PENCE

----------

DEUTSCHE BANK RAISES FUTURE PRICE TARGET TO 2,066 (1,974) PENCE - 'BUY'

----------

BERENBERG RAISES POLYPIPE PRICE TARGET TO 610 (540) PENCE - 'HOLD'

----------

RBC RAISES DUNELM GROUP PRICE TARGET TO 1,450 (1,400) PENCE - 'OUTPERFORM'

----------

CREDIT SUISSE RAISES VICTREX PRICE TARGET TO 2,400 (2,200) PENCE - 'OUTPERFORM'

----------

GOLDMAN SACHS CUTS MICRO FOCUS PRICE TARGET TO 600 (630) PENCE - 'BUY'

----------

BERENBERG RAISES ROYAL MAIL PRICE TARGET TO 355 (280) PENCE - 'HOLD'

----------

GOLDMAN SACHS RAISES ROYAL MAIL PRICE TARGET TO 530 (470) PENCE - 'BUY'

----------

OTHER MAIN MARKET AND AIM

----------

BERENBERG CUTS MJ GLEESON PRICE TARGET TO 840 (842) PENCE - 'BUY'

----------

JEFFERIES CUTS CVS GROUP TO 'HOLD' ('BUY') - TARGET 1,770 (1,420) PENCE

----------

JEFFERIES RESUMES N BROWN WITH 'BUY' - TARGET 95 PENCE

----------

Copyright 2021 Alliance News Limited. All Rights Reserved.

Related Shares

More News
Today 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

Today 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Today 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Today 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe a...

Today 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.